Skip to main content
SpringerLink
Log in

A prognostic score with pretransplant serum ferritin and disease status predicts outcome following reduced-intensity SCT

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007; 109: 4586–4588.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2008; 42: 799–805.

    Article  CAS  PubMed  Google Scholar 

  3. Kataoka K, Nannya Y, Hangaishi A, Imai Y, Chiba S, Takahashi T et al. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2009; 15: 195–204.

    Article  PubMed  Google Scholar 

  4. Kim Y, Kim J, Cheong J, Song J, Min Y . Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies. Acta Haematol 2008; 120: 182–189.

    Article  PubMed  Google Scholar 

  5. Mahindra A, Sobecks R, Rybicki L, Pohlman B, Dean R, Andresen S et al. Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation. Bone Marrow Transplant 2009; 42: 799–805.

    Google Scholar 

  6. Oakes R, Sood N, Pearce R, Swirsky D, Cook G, Gilleece M . Prognostic impact of serum ferritin concentration on survival floowing reduced-intensity conditioned allogeneic haemopoietic SCT. Bone Marrow Transplant 2010; 45: 1754–1755.

    Article  CAS  PubMed  Google Scholar 

  7. Tachibana T, Takasaki H, Tanaka M, Maruta A, Hyo R, Ishigatsubo Y et al. Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome. Bone Marrow Transplant 2011; 46: 150–151.

    Article  CAS  PubMed  Google Scholar 

  8. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)—specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912–2919.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Platzbecker U, Bornhäuser M, Germing U, Stumpf J, Scott BL, Kroger N et al. Red blood cell transfusion-dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS). Biol Blood Marrow Transplant 2008; 14: 1217–1225.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan

    M Tanaka, T Tachibana, A Numata, H Takasaki, K Matsumoto, A Maruta & H Kanamori

  2. Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

    Y Ishigatsubo

Authors
  1. M Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T Tachibana
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Numata
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Takasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Maruta
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y Ishigatsubo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H Kanamori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H Kanamori.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanaka, M., Tachibana, T., Numata, A. et al. A prognostic score with pretransplant serum ferritin and disease status predicts outcome following reduced-intensity SCT. Bone Marrow Transplant 47, 596–597 (2012). https://doi.org/10.1038/bmt.2011.122

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.122

  • Springer Nature Limited

This article is cited by

Search

Navigation